CD206 accelerates hepatocellular carcinoma progression by regulating the tumour immune microenvironment and increasing M2-type polarisation of tumour-associated macrophages and inflammation factor expression DOI Creative Commons
Zhiyuan Mao, Yalin Han, Yinglin Li

и другие.

Discover Oncology, Год журнала: 2024, Номер 15(1)

Опубликована: Сен. 13, 2024

Язык: Английский

Reprogramming tumor-associated macrophages in gastric cancer: a pathway to enhanced immunotherapy DOI Creative Commons
Yibo He, Qianran Hong, Shiliang Chen

и другие.

Frontiers in Immunology, Год журнала: 2025, Номер 16

Опубликована: Март 3, 2025

Gastric cancer (GC) remains a significant global health concern due to its poor prognosis and limited therapeutic options, particularly in advanced stages. Tumor microenvironment (TME), tumor-associated macrophages (TAMs), plays key role tumor progression, immune evasion, therapy resistance. TAMs exhibit plasticity, shifting between pro-inflammatory M1 immunosuppressive M2 phenotypes, with the latter predominating GC contributing outcomes. Recent advancements focus on targeting TAMs, including inhibiting polarization, reprogramming combining TAM-targeted approaches checkpoint inhibitors. Innovations nanotechnology, metabolic reprogramming, pathways such as interleukin-6 C-C motif ligand 2/C-C chemokine receptor 2 further enhance these strategies. However, challenges remain, spatial functional heterogeneity of within TME need for selective avoid disrupting homeostasis. Ongoing research TAM origins, functions, interactions is crucial developing precise effective therapies. These advances hold promise not only improving outcomes but also addressing other cancers similarly complex microenvironments.

Язык: Английский

Процитировано

4

Single-cell RNA sequencing to map tumor heterogeneity in gastric carcinogenesis paving roads to individualized therapy DOI Creative Commons
Jiao Xu,

Bixin Yu,

Fan Wang

и другие.

Cancer Immunology Immunotherapy, Год журнала: 2024, Номер 73(11)

Опубликована: Сен. 13, 2024

Gastric cancer (GC) is a highly heterogeneous disease with complex tumor microenvironment (TME) that encompasses multiple cell types including cells, immune stromal and so on. Cancer-associated cells could remodel the TME influence progression of GC therapeutic response. Single-cell RNA sequencing (scRNA-seq), as an emerging technology, has provided unprecedented insights into complicated biological composition characteristics at molecular, cellular, immunological resolutions, offering new idea for studies. In this review, we discuss novel findings from scRNA-seq datasets revealing origin evolution GC, powerful tool investigating transcriptional dynamics intratumor heterogeneity (ITH) in GC. Meanwhile, demonstrate vital within TME, T B macrophages, play important role progression. Additionally, also overview how facilitates our understanding about effects on individualized therapy patients. Spatial transcriptomes (ST) have been designed to determine spatial distribution capture local intercellular communication networks, enabling further relationship between background particular its functions. summary, other single-cell technologies provide valuable perspective molecular pathological hold promise advancing basic research clinical practice

Язык: Английский

Процитировано

6

The Importance of Extracellular Vesicle Screening in Gastric Cancer: A 2024 Update DOI Open Access
Vasile Bințințan, Claudia Burz,

Irena Pintea

и другие.

Cancers, Год журнала: 2024, Номер 16(14), С. 2574 - 2574

Опубликована: Июль 18, 2024

Extracellular vesicles, or EVs, are membrane-bound nanocompartments produced by tumor cells. EVs carry proteins and nucleic acids from host cells to target cells, where they can transfer lipids, proteomes, genetic material change the function of serve as reservoirs for mobile cellular signals. The collection using less invasive processes has piqued interest many researchers. Exosomes substances that suppress immune system. If results exosome screening negative, immunotherapy will be beneficial GC patients. In this study, we provide an update on based ongoing review papers clinical trials.

Язык: Английский

Процитировано

5

SPP1SRD5A3 signaling axis regulated lymph node metastasis by activating Mucin type O glycan biosynthesis DOI
Tong Xu, Wanli Zhang,

Shaobo Gong

и другие.

The FASEB Journal, Год журнала: 2025, Номер 39(7)

Опубликована: Апрель 2, 2025

Lymph node metastasis (LNM) holds substantial implications for the recurrence and survival of cancer patients, but intricate regulatory mechanisms underlying LNM remain poorly understood. MTOGB was dominantly increased in pan-cancer, significantly activated epithelial cells enriched LNM. Subsequently, we identified a specific cell subpopulation, EC4, located at terminal differentiation trajectory Lineage2. By intersecting differentially expressed genes cluster 2, EC4 Lineage2, six crucial genes. Notably, expression Steroid 5α-reductase 3 (SRD5A3) with progression stages. Knockdown SRD5A3 effectively suppressed MTOGB, blocking both animal models. Nilotinib screened as candidate inhibitor confirmed to remarkably decrease metastasis. SOX4 potential transcription factor SRD5A3, modulated by dramatic increase communication SPP1+ macrophages immune microenvironment. The supernatant from macrophage enhanced SOX4/SRD5A3 metastatic ability cells, this effect reversed deletion SPP1. Collectively, our findings illuminate SPP1-SRD5A3 signaling driver suggest that its blockade could be promising option overcoming

Язык: Английский

Процитировано

0

Harnessing Exosomes: From Tumor Immune Escape to Therapeutic Innovation in Gastric Cancer Immunotherapy DOI

Zhao Jin,

Cheng Zhang, Lin Shen

и другие.

Cancer Letters, Год журнала: 2025, Номер 626, С. 217792 - 217792

Опубликована: Май 22, 2025

Язык: Английский

Процитировано

0

NK cell-derived artificial extracellular vesicles elicit potent anti-tumor efficacy and tumor microenvironment reprogramming capability DOI Creative Commons
Xinyue Zhou, Hang Yuan, Xinyue Zhu

и другие.

Cancer Nanotechnology, Год журнала: 2025, Номер 16(1)

Опубликована: Май 30, 2025

Процитировано

0

IDO1 as a potential diagnostic biomarker for gastric cancer DOI Creative Commons
Yulu Wang,

Yun Jin,

Tongyu Wang

и другие.

Asian Journal of Surgery, Год журнала: 2024, Номер 47(10), С. 4351 - 4353

Опубликована: Июль 3, 2024

Язык: Английский

Процитировано

0

CD206 accelerates hepatocellular carcinoma progression by regulating the tumour immune microenvironment and increasing M2-type polarisation of tumour-associated macrophages and inflammation factor expression DOI Creative Commons
Zhiyuan Mao, Yalin Han, Yinglin Li

и другие.

Discover Oncology, Год журнала: 2024, Номер 15(1)

Опубликована: Сен. 13, 2024

Язык: Английский

Процитировано

0